China Problems Kick in for Apple

Apple (Nasdaq: AAPL) announced its first quarter results that continued to outpace market expectations. However, Apple’s disappointing iPhone sales and China performance did not please the market.

Cloud Stocks: Amazon Includes DeepSeek Model in Bedrock Marketplace

Last week, Amazon (NASDAQ: AMZN) announced its fourth quarter results that surpassed market expectations. However, its stock slumped following a weak outlook.

Meta Uses AI to Drive Monetization

Meta (Nasdaq: META), formerly Facebook, announced its quarterly results that continued to outpace market expectations. Meta has been in the news recently as it pivots its stand on fact checking policies to align with the US government’s views. Its continued investments in AI and future growth engines are helping its stock rise. The company’s stock

Read Full Article »

Cloud Stocks: Microsoft’s AI Hits $13B ARR

Last week, Microsoft (Nasdaq: MSFT) announced its second quarter results that surpassed market expectations. However, its stock slumped following a weak outlook and the buzz around DeepSeek.

AI Unicorns: Rasa Races to Make it in the Conversational AI Market

According to a recent report, the

AI Drug Discovery Startups: Berg Health Focuses AI on Prostrate Cancer and Parkinsons

The high growth AI-drug discovery market has attracted several players. However, the high cost of drug development, and the slow regulatory process associated with drug release has also led to several consolidations. One such story is that of Berg Health.

AI Drug Discovery Startups: Could Insilico Medicine Release the First Drug to be Discovered by AI?

The global artificial intelligence in drug discovery market is projected to grow at 22% CAGR from $1.7 billion in 2023 to reach $11.93 billion by 2033. The healthcare industry is increasingly adopting AI solutions to alleviate the significant financial burdens and potential setbacks that are associated with the drug discovery process. Hong Kong’s InSilico Medicine

Read Full Article »

AI Drug Discovery Stocks: Recursion Pharmaceuticals Has a Long Road Ahead

Among the various use-cases for AI, healthcare has been one of the interesting ones. Recursion Pharmaceuticals (NASDAQ: RXRX) is one such notable player in the industry that has successfully leveraged AI in drug discovery.